Abstract

ABSTRACTBackground Blood-borne viral infections, like hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV), are most common during blood transfusion. Morbidity and mortality resulting from the transfusion of infected blood have far reaching consequences not only for the recipients themselves but also for their families, communities and the wider society.Aims The study was designed to determine the prevalence of HBV, HCV and HIV among voluntary and replacement blood donors of Tripura, India, and to study the trends of HBV, HCV and HIV infections in the population.Materials and methods This study is a retrospective cross-sectional study. The data was collected for consecutive 8 years from 2005 to 2013. Analyses were done in respect of total blood collection and HBV, HCV and HIV infections among the donors.Results Among all donors, 91.8% was voluntary donors and 8.2% was replacement donors. The average HBV, HCV and HIV positivity was 1.2% (95% CI: 1.155-1.255), 0.109% (95% CI: 0.0950.125) and 0.093% (95% CI: 0.080-0.108) respectively. Among these, HBV seropositivity was 1.19% among voluntary donors and 1.33% among replacement donors and, in case of HCV and HIV, the seropositivity among voluntary and replacement donors were 0.109%, 0.11% and 0.089%, 0.145% respectively. HBV positivity was reduced in 8 years, whereas those of HCV and HIV remain unchanged.Conclusion The most important observation of this study is gradual decrease in prevalence of HBV (p = 0.0018), whereas change in prevalence of HCV and HIV was not statistically significant. This might be due to mass hepatitis B vaccination program in Tripura.How to cite this article: Bhaumik P, Debnath K. Prevalence of Blood-Borne Viral Infections among Blood Donors of Tripura. Euroasian J Hepato-Gastroenterol 2014;4(2):79-82.

Highlights

  • Blood transfusion has been an integral and life-saving procedure of modern medical science, since the discovery of human whole blood transfusion in 1818 byDr James Bundell

  • The average hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) positivity was 1.2%, 0.109% and 0.093% respectively

  • HBV positivity was reduced in 8 years, whereas those of HCV and HIV remain unchanged

Read more

Summary

Introduction

Blood transfusion has been an integral and life-saving procedure of modern medical science, since the discovery of human whole blood transfusion in 1818 byDr James Bundell. Unsafe transfusion practices put millions of people at risk of transfusion transmissible infections (TTIs). Despite the availability of improved donor screening technologies and viral inactivation procedures, the risk of TTIs still remains a major concern. Factors, such as blood donation during window period, emergence of newer transmissible pathogens and prevalence of asymptomatic carriers pose a serious challenge to blood safety.[1] Blood-borne viral infections like hepatitis B virus (HBV), hepatitis C virus (HCV). Human immunodeficiency virus (HIV) are the most common during blood transfusion. Blood-borne viral infections, like hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV), are most common during blood transfusion. Morbidity and mortality resulting from the transfusion of infected blood have far reaching consequences for the recipients themselves and for their families, communities and the wider society

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call